Piper Sandler assumed coverage of Colgate-Palmolive (CL) with a Neutral rating and $84 price target The company has strong brands and brand equity along with a “compelling footprint,” particularly in Latin America, the analyst tells investors in a research note. However, Piper believes Colgate’s category headwinds will likely to persist in the near-term.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $82 from $87 at Barclays
- Colgate-Palmolive (CL) Strikes $332M Settlement in Pension Class-Action
- Colgate-Palmolive price target lowered to $90 from $100 at TD Cowen
- Strategic Initiatives and Financial Outlook Drive Buy Rating for Colgate-Palmolive
- Colgate-Palmolive price target lowered to $98 from $105 at BofA